Natco Launches Additional Strengths Of Generic Version Of Revlimid In US

The company has launched 2.5 mg, and 20 mg strengths of the generic version of Revlimid (lenalidomide capsules) through its marketing partner Teva Pharmaceuticals

Topics

Natco Pharma Ltd | United States | pharmaceutical firms

Press Trust of India  |  New Delhi 



pharma, medicine, drugs

Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma, a regulatory filing said.

').insertAfter(".article-content__img");$(".article-content__img div").find('div').remove();

on Friday said it has launched additional strengths for its generic lenalidomide capsules used in the treatment of multiple myeloma, in the US.

The company has launched 2.5 mg, and 20 mg strengths of the generic version of Revlimid (lenalidomide capsules) through its marketing partner Teva Pharmaceuticals, a US affiliate of Teva Pharmaceutical Industries Ltd, Natco Pharma said in a regulatory filing.

"With this launch the (have) made available all the strengths of lenalidomide in the US market," it added.

Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma, the filing said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

First Published: Fri, March 10 2023. 14:01 IST


RECENT NEWS

Coutts Sets Scope On New Continent

Coutts steps into private marketsCoutts, the private bank best known for serving Britain’s wealthiest families and the... Read more

From Cypherpunk To Citadel

How Crypto Moved from the Wild West to the Mainstream Financial SystemA long-form analysis of Bitcoin's journey from fri... Read more

ACB Securities: Building Scale, Trust & Innovation

ACB Securities: Building Scale, Trust and Innovation in Vietnam’s Capital MarketsACB Securities (ACBS) is emerging as ... Read more

War Risk Returns To Markets As VIX Surges

For most of the past year, global markets behaved as though geopolitical risk had largely disappeared. Inflation was eas... Read more

Stablecoin The Future Of Currency?

The payments system is undergoing a quiet but consequential shift. What was once the exclusive preserve of central banks... Read more

BoE Loosens Capital Rules

The Bank of England has taken a significant step towards easing post-crisis regulation by lowering its estimate of the c... Read more